79 related articles for article (PubMed ID: 23548533)
1. A unique case of peroneus brevis/longus myositis in a patient with a STAT3 mutation.
Sterbank J; Marino J; Jhaveri D; Horbal J; Tcheurekdjian H; Hostoffer R
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):204-5. PubMed ID: 23548533
[No Abstract] [Full Text] [Related]
2. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.
Mogensen TH; Jakobsen MA; Larsen CS
Scand J Infect Dis; 2013 Mar; 45(3):235-8. PubMed ID: 22992060
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of autosomal-dominant hyperimmunoglobulin E syndrome.
Garcés P; Garcia-Martin F; Detkova D; Espanol T
J Investig Allergol Clin Immunol; 2012; 22(2):149-52. PubMed ID: 22533245
[No Abstract] [Full Text] [Related]
4. STAT3 mutation in the original patient with Job's syndrome.
Renner ED; Torgerson TR; Rylaarsdam S; Añover-Sombke S; Golob K; LaFlam T; Zhu Q; Ochs HD
N Engl J Med; 2007 Oct; 357(16):1667-8. PubMed ID: 17942886
[No Abstract] [Full Text] [Related]
5. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
[TBL] [Abstract][Full Text] [Related]
6. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
Freeman AF; Domingo DL; Holland SM
Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
[TBL] [Abstract][Full Text] [Related]
7. [Dominant negative STAT-3 mutations in hyper-IgE syndrome].
Dereure O
Ann Dermatol Venereol; 2008 May; 135(5):432. PubMed ID: 18457738
[No Abstract] [Full Text] [Related]
8. STAT3 signaling and the hyper-IgE syndrome.
Levy DE; Loomis CA
N Engl J Med; 2007 Oct; 357(16):1655-8. PubMed ID: 17881746
[No Abstract] [Full Text] [Related]
9. Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.
Watarai A; Niiyama S; Morita M; Bando Y; Minegishi Y; Katsuoka K
Eur J Dermatol; 2011; 21(2):254-5. PubMed ID: 21454152
[No Abstract] [Full Text] [Related]
10. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.
Kim HJ; Kim JH; Shin YK; Lee SI; Ahn KM
J Allergy Clin Immunol; 2009 Apr; 123(4):956-8. PubMed ID: 19348930
[No Abstract] [Full Text] [Related]
11. Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES).
Spielberger BD; Woellner C; Dueckers G; Sawalle-Belohradsky J; Hagl B; Anslinger K; Bayer B; Siepermann K; Niehues T; Grimbacher B; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2012 Dec; 130(6):1426-8. PubMed ID: 22981789
[No Abstract] [Full Text] [Related]
12. [STAT3 mutation identified in patients with Hyper-IgE syndrome].
Picard C
Med Sci (Paris); 2008 Mar; 24(3):242-3. PubMed ID: 18334168
[No Abstract] [Full Text] [Related]
13. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
[TBL] [Abstract][Full Text] [Related]
14. Hyperimmunoglobulin E syndrome with a novel STAT3 mutation.
Anolik R; Elmariah S; Lehrhoff S; Votava HJ; Martiniuk FT; Levis W
Dermatol Online J; 2009 Aug; 15(8):16. PubMed ID: 19891924
[TBL] [Abstract][Full Text] [Related]
15. [Hyper-IgE recurrent infection syndrome: pathogenesis, diagnosis and therapeutic management].
Guisado Vasco P; Fraile Rodríguez G; Arechaga Uriarte S
Rev Clin Esp; 2011 Nov; 211(10):520-6. PubMed ID: 21700278
[TBL] [Abstract][Full Text] [Related]
16. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y; Saito M
Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
[TBL] [Abstract][Full Text] [Related]
18. [Hyperimmunoglobulin E syndrome (Job's syndrome)].
Nikolov A; Mihova M
Akush Ginekol (Sofiia); 2011; 50(5):55-9. PubMed ID: 22482162
[TBL] [Abstract][Full Text] [Related]
19. Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent-infection (Job's) syndrome.
Donabedian H; Alling DW; Gallin JI
N Engl J Med; 1982 Jul; 307(5):290-2. PubMed ID: 6806658
[No Abstract] [Full Text] [Related]
20. Hyper-IgE syndrome: dental implications.
Esposito L; Poletti L; Maspero C; Porro A; Pietrogrande MC; Pavesi P; Dellepiane RM; Farronato G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):147-53. PubMed ID: 22769403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
